Astrana Health, Inc. (ASTH) Return on equity 2017–2025
Astrana Health, Inc. (ASTH) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
2.9%FY2025 · since FY2017: 16.1% → 2.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 2.9% | -3.2 pp |
| FY2024 | 6.1% | -3.8 pp |
| FY2023 | 9.9% | +1.6 pp |
| FY2022 | 8.3% | -7.1 pp |
| FY2021 | 15.4% | +4.0 pp |
| FY2020 | 11.4% | +4.0 pp |
| FY2019 | 7.4% | +1.4 pp |
| FY2018 | 6.0% | -10.1 pp |
| FY2017 | 16.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice